Hyperdynamic circulation and serotonin levels in patients with liver cirrhosis

Jugoslovenska Medicinska Biohemija

Volumn 23, Issue 1, 2004, Pages 31-35

  Ćulafić, Dorde ^a   Dukić, Vladimir ^a   Mirković, Duško ^a   Karamarković, Aleksandar ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Hyperdinamic circulation; Liver cirrhosis; Serotonin

Indexed keywords

ENDOTHELIN 1; NITRIC OXIDE; PROSTAGLANDIN; SEROTONIN;

ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CORRELATION ANALYSIS; ESOPHAGUS VARICES; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; PATHOGENESIS; PORTAL HYPERTENSION; PORTAL VEIN; SEROTONIN BLOOD LEVEL; SOLID PHASE EXTRACTION; SPLENOMEGALY; THROMBOCYTE COUNT; URINE LEVEL;

EID: 1842427405     PISSN: 03543447     EISSN: None     Source Type: Journal    
DOI: 10.2298/JMH0401031C     Document Type: Article

References (30)

1. Bosch J, Piscueta P, Feu F, Fernandez M, Garcia-Pagan JC. Pathophysiology of portal hypertension. Gastroentrol Clin North Am 1992; 21: 114-7.
2. Schreier RW, Arrozo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripherial arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and wather retentiojn in cirrhosis. Hepatology 1988; 8: 1151-8.
3. La Villa G, Barletta G, Pantaleo P, Dek Bene R, Vizzutti F, Vecchiarino S. Hemodynamic, renal, ane endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis. Hepatology 2001; 34: 19-27.
4. Chan CC, Wang SS, Lee FY, Chang FY, Lin HC, Chu CJ. Hepatology 2001; 33: 816-20.
5. Takkenberg B, Endert E, Van Ingen HE, Ackermans M. Improved method for the determination of serotonin in plasma by high-permormance liquid chromatography using on-line sample pre-treatmant. J Chrom 1991; 565: 430-35.
6. Zhen Y, Phillis R. Analysis of biogenic amines and their acidic metabolites by reversed-phase liquid chromatography with electrochemical detection. J Liquid Chrom 1990; 13: 2161-77.
7. Mundschenk DD, Conolly DP, White JG, Brunning RD. An improved technique for the electronic measurement of platelet size and shape. J Clin Lab Med 1976; 88: 301-15.
8. Jovanović S, Mirković D, Majkić-Singh N. References values of serotonin in urine and plasma determined liquid chromatography with electrochemical detection. Clin Lab 1998; 14: 263-8.
9. Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993; 18: 1139-43.
10. Laffi G, Foschi M, Masini E, Simoni A, Mugnai L, La Villa G, et al. Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. Hepatology 1995; 22: 1666-73.
11. Campillo B, Chabrier PE, Pelle G, Sediame S, Atlan G, Fouet P, et al. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis. Hepatology 1995; 22: 1423-9.
12. Gupta TK, Torner M, Chung MK, Groszman RJ. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology 1998; 28: 926-31.
13. Shah V, Garcia-Cardena G, Sessa WC, Groszman RJ. The hepatic circulation in health and disease: report of a single-topic symposium. Hepatology 1998; 27: 279-88.
14. Chan CC, Lee FY, Wang SS, Chang FY, Lin HC, Chu CJ, et al. Effects of vasopression on portal-systemic collaterals of portal hypertensive rats: role of nitric oxide and prostaglandin. Hepatology 1999; 30: 630-5.
15. Hou MC, Cahill PA, Zhang S, Wang YN, Hendricson RJ, Redmond EM, et al. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdinamic circulation. Hepatology 1998; 27: 20-7.
16. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-5.
17. Wang HG, Shibamoto T, Miyahara T. Endothelin-1 selectively contracts portal vein through both ETA and ETB receptors in isolated rabbit liver. Am J Physiol 1997; 36: 1036-43.
18. Rockey D. The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide. Hepatology 1997; 25: 2-5.
19. Nagusea N, Dhar DK, Yamanoi A, Yamaguchi E, Udagawa J, Yamamoto A. Production and release of endothelin-1 from the gut and spleen in portal hypertension due to cirrhosis. Hepatology 2000; 31: 1107-14.
20. Borcsiczky D, Szalay F, Tekes K, Tarcali J, Magyar K, Chatel R. Platelet serotonin (5-HT) content is decreased in patients with alcoholic liver cirrhosis, but elevated in Gilbert's syndrome. J Hepatol 1996; 25: 781-2.
21. Vorobioff J, Garcia-Tsao G, Groszman R. Long-term hemodynamic effects of ketanserin, a 5-hydroxytryptamine blocker, in portal hypertensive patients. Hepatology 1989; 9: 88-91.
22. Rosen MH, Yoshimura N, Hodgman JM, Fischer JE. Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology 1977; 72: 483-7.
23. Bergeron M, Pomier Layrargues G, Butterworth RF. Aromatic and branched-chain amino acids in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Metab Brain Dis 1989; 4: 169-76.
24. Bergeron M, Reader TA, Pomier Layrargues G, Butterworth RF. Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem Res 1989; 9: 853-9.
25. Rao VL, Pomier Layrargues G, Butterworth RF. Increased activities of MAOA and MAOB in autpsied brain tissue from cirrhotic patients with hepatic encephalopathy. Brain Research 1993; 621: 349-52.
26. Mac Lean MR. Endothelin-1 and serotonin: Mediators of primary and secondary pulmonary hypertension? J Lab Clin Med 1999; 134: 105-14.
27. Marasini B, Biondi ML, Agostini A. Platelet and plasma serotonin in patients with liver cirrhosis. J Clin Chem Clin Biochem 1989; 27: 419-21.
28. Laffi G, Marra F, Gresele P. Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation. Gastroenterology 1992; 103: 641-6.
29. Rossle M, Herz R, Mullen KD, Jones DB. The disposition of intravenous L-tryptophan in healthy subjects and in patients with liver disease. Br J Clin Pharmacol 1986; 22: 633-8.
30. Beaudry P, Hadengue A, Callebert J. Blood and plasma 5-hydroxytryptamine levels in patients with cirrhosis. Hepatology 1994; 20: 800-3.